Acute myeloid leukemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Acute myeloid leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute myeloid leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardigram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute myeloid leukemia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute myeloid leukemia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute myeloid leukemia secondary prevention
CDC on Acute myeloid leukemia secondary prevention
Acute myeloid leukemia secondary prevention in the news
Blogs on Acute myeloid leukemia secondary prevention
Directions to Hospitals Treating Acute myeloid leukemia
Risk calculators and risk factors for Acute myeloid leukemia secondary prevention

Overview

There is no established method for secondary prevention of acute myeloid leukemia.

Secondary Prevention

There is no established method for secondary prevention of acute myeloid leukemia or other myeloproliferative disorders. Routine monitoring of the complete blood count on a yearly basis is sufficient for monitoring.